These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34070835)

  • 1. Associations between High-Density Lipoprotein Functionality and Major Adverse Cardiovascular Events in Patients Who Have Undergone Coronary Computed Tomography Angiography.
    Inoue H; Shiga Y; Norimatsu K; Tashiro K; Futami M; Suematsu Y; Sugihara M; Nishikawa H; Katsuda Y; Miura SI
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34070835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between high-density lipoprotein cholesterol levels and major adverse cardiovascular events in patients who underwent coronary computed tomography angiography: FU-CCTA registry.
    Kawahira Y; Shiga Y; Inoue H; Suematsu Y; Tashiro K; Kato Y; Fujimi K; Takamiya Y; Kuwano T; Sugihara M; Miura SI
    Heart Vessels; 2021 Oct; 36(10):1457-1465. PubMed ID: 33744994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Density Lipoprotein Cholesterol Efflux Capacity as a Novel Prognostic Surrogate for Coronary Artery Disease.
    Hisauchi I; Ishikawa T; Ayaori M; Uto-Kondo H; Koshikawa Y; Ukaji T; Nakamura H; Mizutani Y; Taguchi I; Nakajima T; Mutoh M; Ikewaki K
    J Atheroscler Thromb; 2021 Jul; 28(7):696-702. PubMed ID: 32908115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High density lipoprotein proteome is associated with cardiovascular risk factors and atherosclerosis burden as evaluated by coronary CT angiography.
    Gordon SM; Chung JH; Playford MP; Dey AK; Sviridov D; Seifuddin F; Chen YC; Pirooznia M; Chen MY; Mehta NN; Remaley AT
    Atherosclerosis; 2018 Nov; 278():278-285. PubMed ID: 30347343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease.
    Norimatsu K; Kuwano T; Miura SI; Shimizu T; Shiga Y; Suematsu Y; Miyase Y; Adachi S; Nakamura A; Imaizumi S; Iwata A; Nishikawa H; Uehara Y; Saku K
    Heart Vessels; 2017 Jan; 32(1):30-38. PubMed ID: 27106918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses.
    van Capelleveen JC; Kastelein JJ; Zwinderman AH; van Deventer SJ; Collins HL; Adelman SJ; Round P; Ford J; Rader DJ; Hovingh GK
    J Clin Lipidol; 2016; 10(5):1137-1144.e3. PubMed ID: 27678430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis.
    Qiu C; Zhao X; Zhou Q; Zhang Z
    Lipids Health Dis; 2017 Nov; 16(1):212. PubMed ID: 29126414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis.
    Lee JJ; Chi G; Fitzgerald C; Kazmi SHA; Kalayci A; Korjian S; Duffy D; Shaunik A; Kingwell B; Yeh RW; Bhatt DL; Gibson CM
    Front Cardiovasc Med; 2021; 8():774418. PubMed ID: 34966797
    [No Abstract]   [Full Text] [Related]  

  • 9. HDL (High-Density Lipoprotein) Cholesterol Efflux Capacity Is Associated With Incident Cardiovascular Disease in the General Population.
    Ebtehaj S; Gruppen EG; Bakker SJL; Dullaart RPF; Tietge UJF
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1874-1883. PubMed ID: 31315436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline levels of serum high sensitivity C reactive protein and lipids in predicting the residual risk of cardiovascular events in Chinese population with stable coronary artery disease: a prospective cohort study.
    Dai W; Zhang Z; Zhao S
    Lipids Health Dis; 2018 Dec; 17(1):273. PubMed ID: 30509306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease.
    Kosmas CE; Martinez I; Sourlas A; Bouza KV; Campos FN; Torres V; Montan PD; Guzman E
    Drugs Context; 2018; 7():212525. PubMed ID: 29623098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio on long-term outcome in patients undergoing percutaneous coronary intervention.
    Matsumoto I; Miyake Y; Mizukawa M; Takagi Y
    Circ J; 2011; 75(4):905-10. PubMed ID: 21325724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Triglycerides to High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio Predicts Long-Term Mortality in High-Risk Patients.
    Sultani R; Tong DC; Peverelle M; Lee YS; Baradi A; Wilson AM
    Heart Lung Circ; 2020 Mar; 29(3):414-421. PubMed ID: 31014557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four-year clinical outcome in asymptomatic patients undergoing coronary computed tomography angiography.
    Zhang KY; Gai LY; Gai JJ; He B; Guan ZW
    Chin Med J (Engl); 2013; 126(9):1630-5. PubMed ID: 23652041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Cardiac Rehabilitation on High-Density Lipoprotein-mediated Cholesterol Efflux Capacity and Paraoxonase-1 Activity in Patients with Acute Coronary Syndrome.
    Furuyama F; Koba S; Yokota Y; Tsunoda F; Shoji M; Kobayashi Y
    J Atheroscler Thromb; 2018 Feb; 25(2):153-169. PubMed ID: 28855433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoprotein cholesterol efflux capacity is not associated with atherosclerosis and prevalence of cardiovascular outcome: The CODAM study.
    Josefs T; Wouters K; Tietge UJF; Annema W; Dullaart RPF; Vaisar T; Arts ICW; van der Kallen CJH; Stehouwer CDA; Schalkwijk CG; Goldberg IJ; Fisher EA; van Greevenbroek MMJ
    J Clin Lipidol; 2020; 14(1):122-132.e4. PubMed ID: 31791716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of high-density lipoprotein particle concentration with cardiovascular risk following acute coronary syndrome: A case-cohort analysis of the dal-Outcomes trial.
    Salahuddin T; Kittelson J; Tardif JC; Shah PK; Olsson AG; Nicholls SJ; Leitersdorf E; Leiter LA; Kallend D; Black DM; Barter PJ; Ballantyne CM; Schwartz GG
    Am Heart J; 2020 Mar; 221():60-66. PubMed ID: 31927126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From HDL-cholesterol to HDL-function: cholesterol efflux capacity determinants.
    Rhainds D; Tardif JC
    Curr Opin Lipidol; 2019 Apr; 30(2):101-107. PubMed ID: 30672808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.